Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03981419 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty
A Phase 2 study, sponsored by Alkahest.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
NCT03981419 is a Phase 2 study that has completed, run by Alkahest. The registered enrollment target is 38 participants.
The verdict
NCT03981419, a Phase 2 study, has completed, sponsored by Alkahest.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study will evaluate the safety, tolerability and effect of GRF6021 on clinical recovery parameters in participants undergoing primary hip or knee arthroplasty.
Interventions
- OTHER Placebo
- BIOLOGICAL GRF6021
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-07-12 |
| Est. Completion | 2021-03-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03981419
The ClinicalTrials.gov registry entry for NCT03981419 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alkahest, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03981419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03981419 about?
NCT03981419 is a clinical study titled "A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty". This study will evaluate the safety, tolerability and effect of GRF6021 on clinical recovery parameters in participants undergoing primary hip or knee arthroplasty.
What is the current status of trial NCT03981419?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2019-07-12. Estimated completion is 2021-03-04.
What interventions are being tested in trial NCT03981419?
The interventions under investigation include: Placebo (OTHER), GRF6021 (BIOLOGICAL).
Who is sponsoring clinical trial NCT03981419?
This trial is sponsored by Alkahest, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.